SAB Biotherapeutics Announces Q1 2024 Financial Results and Provides Company Updates
20 mai 2024 17h45 HE
|
SAB Biotherapeutics, Inc.
SAB Biotherapeutics Announces Q1 2024 Financial Results
Wilhelm Sonesson Offers Shareholders Opportunity to Acquire Other Operations
25 mars 2002 12h41 HE
|
Wilhelm Sonesson
MALMO, Sweden, March 25, 2002 (PRIMEZONE) -- The Board of Wilhelm Sonesson has resolved to recommend to the Annual General Meeting on April 24, 2002 a division of current operations into two separate...